1. Vision of relevant technologic progress for the next two decades
Thomas J. Fogarty, MD 
Journal of Vascular Surgery 
Volume 24, Issue 2, Pages (August 1996)
DOI: /S (96)
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2. Fig. 1
Illustration of VasoSeal vascular hemostasis device providing puncture site sealing by application of collagen to outside of femoral artery (photo courtesy of Datascope Corp., Montvale, N.J.).
Journal of Vascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3. Fig. 2
Illustration of Angio-Seal device mode of action used to seal femoral access site. After absorbable anchor has been inserted into artery lumen (A), it is withdrawn by pulley type of absorbable suture until secure at artery wall. Absorbable collagen sponge is then deployed outside artery, compressing anchor against vessel surface to create a seal (B). All components are absorbed in 60 to 90 days (photo courtesy of Sherwood-Davis & Geck, St. Louis).
Journal of Vascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

4. Fig. 2
Illustration of Angio-Seal device mode of action used to seal femoral access site. After absorbable anchor has been inserted into artery lumen (A), it is withdrawn by pulley type of absorbable suture until secure at artery wall. Absorbable collagen sponge is then deployed outside artery, compressing anchor against vessel surface to create a seal (B). All components are absorbed in 60 to 90 days (photo courtesy of Sherwood-Davis & Geck, St. Louis).
Journal of Vascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

5. Fig. 3
Illustration of Prostar percutaneous vascular surgical closure device. A, Sheath loaded with four needles carrying sutures is placed into artery; B, needles are deployed through artery wall as device handle is pulled upward; C, square knots are tied in each suture and delivered to artery surface with knot pusher. Complete hemostasis is achieved with percutaneous approach (photo courtesy of Perclose, Inc., Menlo Park, Calif.).
Journal of Vascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

6. Fig. 3
Illustration of Prostar percutaneous vascular surgical closure device. A, Sheath loaded with four needles carrying sutures is placed into artery; B, needles are deployed through artery wall as device handle is pulled upward; C, square knots are tied in each suture and delivered to artery surface with knot pusher. Complete hemostasis is achieved with percutaneous approach (photo courtesy of Perclose, Inc., Menlo Park, Calif.).
Journal of Vascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

7. Fig. 3
Illustration of Prostar percutaneous vascular surgical closure device. A, Sheath loaded with four needles carrying sutures is placed into artery; B, needles are deployed through artery wall as device handle is pulled upward; C, square knots are tied in each suture and delivered to artery surface with knot pusher. Complete hemostasis is achieved with percutaneous approach (photo courtesy of Perclose, Inc., Menlo Park, Calif.).
Journal of Vascular Surgery  , DOI: ( /S (96) )
Copyright © 1996 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions